Bertolucci, R.V.; Klein, B.; Pase, C.C.; de Melo, V.C.; Bagatini, M.D.
Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications. Pharmaceuticals 2026, 19, 913.
https://doi.org/10.3390/ph19060913
AMA Style
Bertolucci RV, Klein B, Pase CC, de Melo VC, Bagatini MD.
Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications. Pharmaceuticals. 2026; 19(6):913.
https://doi.org/10.3390/ph19060913
Chicago/Turabian Style
Bertolucci, Rayana Vilela, Bruna Klein, Camilla Casarin Pase, Vitória Capelli de Melo, and Margarete Dulce Bagatini.
2026. "Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications" Pharmaceuticals 19, no. 6: 913.
https://doi.org/10.3390/ph19060913
APA Style
Bertolucci, R. V., Klein, B., Pase, C. C., de Melo, V. C., & Bagatini, M. D.
(2026). Immunosuppressive Pathways in Cutaneous Melanoma: Functional Integration Between PD-1 and CD73 and Therapeutic Implications. Pharmaceuticals, 19(6), 913.
https://doi.org/10.3390/ph19060913